Didier Laureillard

2.7k total citations
84 papers, 1.3k citations indexed

About

Didier Laureillard is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Didier Laureillard has authored 84 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Infectious Diseases, 54 papers in Epidemiology and 28 papers in Virology. Recurrent topics in Didier Laureillard's work include HIV, Drug Use, Sexual Risk (34 papers), HIV/AIDS Research and Interventions (32 papers) and HIV Research and Treatment (28 papers). Didier Laureillard is often cited by papers focused on HIV, Drug Use, Sexual Risk (34 papers), HIV/AIDS Research and Interventions (32 papers) and HIV Research and Treatment (28 papers). Didier Laureillard collaborates with scholars based in France, United States and Vietnam. Didier Laureillard's co-authors include Catherine Quillet, Laurent Ferradini, Narom Prak, Nicolas Nagot, Marcelo Fernandez, Laurence Weiss, Christophe Piketty, Yoann Madec, Jean‐François Delfraissy and Jean‐Pierre Molès and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Didier Laureillard

82 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Didier Laureillard France	20	858	759	354	143	141	84	1.3k
F Mulcahy Ireland	19	800 0.9×	594 0.8×	316 0.9×	81 0.6×	47 0.3×	66	1.4k
Mauro Zaccarelli Italy	25	1.2k 1.4×	498 0.7×	953 2.7×	162 1.1×	87 0.6×	91	1.7k
Isabelle Ravaux France	17	613 0.7×	420 0.6×	329 0.9×	201 1.4×	33 0.2×	48	1.1k
Chuanyi Ning China	20	680 0.8×	528 0.7×	319 0.9×	37 0.3×	34 0.2×	74	1.1k
Serge Eholié Ivory Coast	20	948 1.1×	462 0.6×	556 1.6×	162 1.1×	41 0.3×	52	1.2k
Christopher B. Hurt United States	22	1.0k 1.2×	727 1.0×	491 1.4×	146 1.0×	20 0.1×	53	1.3k
Benedetta Longo Italy	16	370 0.4×	357 0.5×	124 0.4×	92 0.6×	51 0.4×	29	664
Robert A. Myers United States	17	678 0.8×	443 0.6×	250 0.7×	23 0.2×	122 0.9×	40	1.2k
Jia‐Hua Zheng United States	19	914 1.1×	386 0.5×	489 1.4×	47 0.3×	22 0.2×	40	1.2k
Susan L. Ford United States	22	1.5k 1.8×	391 0.5×	1.1k 3.1×	97 0.7×	31 0.2×	56	1.8k

Countries citing papers authored by Didier Laureillard

Since Specialization

Citations

This map shows the geographic impact of Didier Laureillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Laureillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Laureillard more than expected).

Fields of papers citing papers by Didier Laureillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Laureillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Laureillard. The network helps show where Didier Laureillard may publish in the future.

Co-authorship network of co-authors of Didier Laureillard

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Laureillard. A scholar is included among the top collaborators of Didier Laureillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Laureillard. Didier Laureillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sturny-Leclère, Aude, Anani Badjé, Dea Garcia‐Hermoso, et al.. (2025). Histoplasma Antigenuria Prevalence in Patients With Advanced HIV Disease in Côte d’Ivoire: A Prospective Trial Ancillary Study. Clinical Infectious Diseases. 81(5). 950–958. 1 indexed citations

Coelho, Lara E., Corine Chazallon, Didier Laureillard, et al.. (2024). Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial. Open Forum Infectious Diseases. 11(3). ofae035–ofae035. 2 indexed citations

Hai, Vinh Vu, Phạm Minh Khuê, Khuat Thi Hai Oanh, et al.. (2023). Gender, homelessness, hospitalization and methamphetamine use fuel depression among people who inject drugs: implications for innovative prevention and care strategies. Frontiers in Psychiatry. 14. 1233844–1233844. 5 indexed citations

Madec, Yoann, Eric Nerrienet, Laurence Borand, et al.. (2023). Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153). Pathogens. 12(10). 1241–1241. 1 indexed citations

Gris, Jean‐Christophe, Taissa Pereira dos Santos, Paul Loubet, et al.. (2023). Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study. Thrombosis Research. 222. 85–95. 2 indexed citations

Grenga, Lucia, Olivier Pible, Guylaine Miotello, et al.. (2022). Taxonomical and functional changes in COVID ‐19 faecal microbiome could be related to SARS‐CoV ‐2 faecal load. Environmental Microbiology. 24(9). 4299–4316. 29 indexed citations

Castro, Nathalie De, Kévin Jean, Rodrigo Escada, et al.. (2022). Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis. Open Forum Infectious Diseases. 9(12). ofac628–ofac628. 2 indexed citations

Ory, Jérôme, Vinh Vu Hai, Julien Crouzet, et al.. (2022). Impact of Infection Control on Prevalence of Surgical Site Infections in a Large Tertiary Care Hospital in Haiphong City. Antibiotics. 12(1). 23–23. 1 indexed citations

Giang, Hoang Thi, Phạm Minh Khuê, Catherine Quillet, et al.. (2022). Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam. AIDS and Behavior. 27(6). 1989–1997. 2 indexed citations

10.

Trang, Nguyễn Thu, Hoang Thi Giang, Duc Nguyen, et al.. (2022). How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation. Harm Reduction Journal. 19(1). 6–6. 9 indexed citations

11.

Rapoud, Delphine, Catherine Quillet, Phạm Minh Khuê, et al.. (2020). Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C). BMJ Open. 10(11). e039234–e039234. 8 indexed citations

12.

Bordes, Claire, Géraldine Leguelinel-Blache, Didier Laureillard, et al.. (2020). Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review. Clinical Microbiology and Infection. 26(9). 1161–1170. 21 indexed citations

13.

Roger, Claire, Laurent Müller, Robin Stéphan, et al.. (2019). Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case report. BMC Infectious Diseases. 19(1). 636–636. 7 indexed citations

14.

Jarlais, Don C. Des, Phạm Minh Khuê, Jonathan Feelemyer, et al.. (2018). Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Drug and Alcohol Dependence. 185. 106–111. 31 indexed citations

15.

Tudesq, Jean‐Jacques, Catherine Dunyach‐Remy, Christophe Combescure, et al.. (2017). Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients. PLoS ONE. 12(9). e0183372–e0183372. 10 indexed citations

16.

Jarlais, Don C. Des, Kamyar Arasteh, Jonathan Feelemyer, et al.. (2017). Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. AIDS and Behavior. 22(7). 2161–2171. 13 indexed citations

17.

Lan, Nguyễn Thị Ngọc, Nguyen Hong Duc, Nguyen Huy Dung, et al.. (2013). The ethics of a clinical trial when the protocol clashes with international guidelines [Unresolved issues]. Public Health Action. 3(2). 97–102. 1 indexed citations

18.

Charpentier, Charlotte, Didier Laureillard, Christophe Piketty, et al.. (2010). High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors. AIDS. 24(6). 867–873. 36 indexed citations

19.

Weiss, Laurence, Marianne Burgard, Marie‐Laure Chaix, et al.. (2002). Immunological and virological features of HIV‐infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor‐based therapy. HIV Medicine. 3(1). 12–20. 8 indexed citations

20.

Laureillard, Didier, Christophe Paquet, & Denis Malvy. (1998). Ciprofloxacine dans le traitement de la dysenterie à Shigella dysenteriae de type 1 lors d’une épidémie chez les réfugiés rwandais à Goma en 1994. Cahiers d'études et de recherches francophones / Santé. 8(4). 303–305. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact